SYRS Syros Pharmaceuticals Inc

Syros Pharmaceuticals Inc is a biopharmaceutical company pioneering an understanding of the region of the genome controlling the activation and repression of genes.

As of 09/30/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/30/2016
Outstanding shares:  6,300,529
Average volume:  3,660,004
Market cap:   $36,795,089
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMGBJ92
Valuation   (See tab for details)
PE ratio:   -0.42
PB ratio:   6.45
PS ratio:   1.53
Return on equity:   -155.36%
Net income %:   -404.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy